SEC Form 4 · accession 0001012975-16-001439
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas G. Cole
Director
Period of report
Aug 11, 2016
Accepted (ET)
Aug 15, 2016 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 11, 2016 | J | 1,485 | — | A | 1,485 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On August 11, 2016, Flagship Ventures Fund IV, L.P. ("Flagship IV") and Flagship Ventures Fund IV-Rx, L.P. ("Flagship IV-Rx") distributed to its limited partners and sole general partner, Flagship Ventures Fund IV General Partner, LLC ("Flagship IV LLC"), pro rata and without consideration, 1,200,000 shares and 300,000 shares, respectively, of the Issuer's common stock. Flagship IV LLC, in turn, distributed to its members, pro rata and without consideration, the 50,261 shares and 10 shares it received from Flagship IV and Flagship IV-Rx, respectively. Mr. Cole, a member of Flagship IV LLC, received 1,485 shares through such distribution.